Literature DB >> 3946972

The "red man's syndrome" and slow infusion of vancomycin.

R L Davis, A L Smith, J R Koup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3946972     DOI： 10.7326/0003-4819-104-2-285_2

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

1.  Comparative Study of Teicoplanin vs Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteraemia.

Authors:  C Y Liu; W S Lee; C P Fung; N C Cheng; C L Liu; S P Yang; S L Chen
Journal:  Clin Drug Investig       Date:  1996-08       Impact factor: 2.859

2.  Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions.

Authors:  D P Healy; J V Sahai; S H Fuller; R E Polk
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

3.  Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome".

Authors:  J Sahai; D P Healy; M J Shelton; J S Miller; S J Ruberg; R Polk
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

4.  Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin.

Authors:  M J Rybak; E M Bailey; L H Warbasse
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 5.  Teicoplanin in perspective. A critical comparison with vancomycin.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1991-08-23

6.  Red man syndrome.

Authors:  Soupramanien Sivagnanam; Dirk Deleu
Journal:  Crit Care       Date:  2002-12-23       Impact factor: 9.097

7.  Red man syndrome following the use of vancomycin-loaded bone cement in the primary total knee replacement: A case report.

Authors:  Chu-Ting Chen; Khai-Jing Ng; Yu Lin; Ming-Chang Kao
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.